Health Innovation KSS appoints two non-executive directors to support next phase of growth

Health Innovation Kent Surrey Sussex (KSS) has welcomed new expertise to its Board spanning healthcare investment, medical technology translation and commercial innovation. Nicolas Huber and Gautam Kainth have been appointed as non-executive directors, strengthening the organisation’s ability to accelerate the adoption and spread of innovation across health and care.

Jane Ollis, Chair of Health Innovation KSS:

“We are delighted to welcome Nicolas and Gautam to our Board. They join us at a pivotal moment for Health Innovation Kent Surrey Sussex as we prepare to launch our strategy to 2030. Their insight and challenge will help us strengthen our partnerships across the health and life sciences sectors, build on our growing leadership in data, digital and AI, and maximise the impact we deliver for patients, communities and the wider health and care system.”

Dr Nicolas Huber is Director of Commercial Operations and Partnerships at the London Institute for Healthcare Engineering at King’s College London, where he leads one of the UK’s leading medical device translation programmes. He brings extensive experience in healthcare innovation, commercialisation and technology adoption, having previously served as Director of Innovation at King’s College London, CEO of a University of Cambridge spin-out and mentor to health technology start-ups.

Gautam Kainth is Managing Partner at TCP Health Ventures, a leading medtech-focused healthcare fund, and brings more than two decades of experience supporting healthcare innovation, investment and growth. Having overseen the deployment of more than US$1 billion in capital globally, he offers deep expertise in helping innovative health technologies move from development to scale. His experience across the life sciences, medical technology and investment sectors will support Health Innovation KSS as it strengthens partnerships with innovators and expands its work in data, digital and AI enabled innovation.

On their appointment:

Dr Huber:  “As a long-time resident of Sussex, I care deeply about serving our local people and communities. I am pleased to be joining the Health Innovation KSS’s Board to help drive its mission to improve health and care across the region. I am looking forward to working with my fellow Board members and senior leadership to leverage innovation to help secure the long-term financial sustainability of both the HIN and the NHS.”

Gautam Kainth:  “I’m delighted to join Health Innovation KSS at such an important time. Through my experience, I’ve seen how hard it is for promising technologies to cross the gap between pilot and scale. I look forward to working with the board and executive team to strengthen partnerships with investors, innovators and the NHS, and to help ensure the best ideas reach patients and communities across Kent, Surrey and Sussex faster.”